Manorama Industries Ltd
Manorama Industries is engaged in manufacturing specialty fats and butter made from exotic seeds and nuts. [1]
- Market Cap ₹ 7,012 Cr.
- Current Price ₹ 1,178
- High / Low ₹ 1,250 / 289
- Stock P/E 116
- Book Value ₹ 63.5
- Dividend Yield 0.03 %
- ROCE 13.4 %
- ROE 12.6 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 18.5 times its book value
- Company has a low return on equity of 11.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 | 104 | 133 | 131 | 145 | 210 | 102 | 188 | 203 | 279 | 351 | 457 | 557 | |
| 101 | 101 | 129 | 127 | 143 | 193 | 73 | 144 | 168 | 240 | 294 | 384 | 448 | |
| Operating Profit | -0 | 4 | 4 | 4 | 3 | 17 | 29 | 44 | 35 | 39 | 56 | 74 | 108 |
| OPM % | -0% | 4% | 3% | 3% | 2% | 8% | 28% | 23% | 17% | 14% | 16% | 16% | 19% |
| 3 | 1 | 1 | 1 | 1 | 2 | 3 | 6 | 6 | 8 | 6 | 13 | 15 | |
| Interest | 1 | 3 | 3 | 2 | 1 | 2 | 5 | 10 | 10 | 6 | 9 | 20 | 29 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | 8 | 8 | 11 | 14 | 17 |
| Profit before tax | 1 | 1 | 2 | 2 | 2 | 16 | 27 | 32 | 22 | 34 | 43 | 53 | 78 |
| Tax % | 32% | 34% | 34% | 36% | 33% | 38% | 28% | 28% | 35% | 28% | 31% | 25% | |
| 1 | 1 | 1 | 1 | 1 | 10 | 19 | 23 | 15 | 24 | 30 | 40 | 60 | |
| EPS in Rs | 0.94 | 1.09 | 1.23 | 1.08 | 1.28 | 2.63 | 3.43 | 4.20 | 2.62 | 4.05 | 5.00 | 6.73 | 10.10 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 35% |
| 3 Years: | 31% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 15% |
| 3 Years: | 40% |
| TTM: | 61% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 78% |
| 3 Years: | 62% |
| 1 Year: | 189% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 11 | 11 | 11 | 12 | 12 | 12 | 12 |
| Reserves | 6 | 7 | 8 | 11 | 12 | 17 | 93 | 116 | 134 | 256 | 286 | 325 | 367 |
| 11 | 12 | 4 | 5 | 0 | 18 | 24 | 119 | 85 | 108 | 110 | 346 | 370 | |
| 8 | 1 | 3 | 3 | 8 | 3 | 5 | 42 | 24 | 19 | 16 | 53 | 39 | |
| Total Liabilities | 27 | 22 | 17 | 21 | 23 | 45 | 133 | 289 | 254 | 396 | 424 | 737 | 788 |
| 3 | 3 | 3 | 3 | 3 | 3 | 6 | 51 | 57 | 55 | 97 | 129 | 175 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 16 | 0 | 0 | 42 | 50 | 42 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 23 | 19 | 14 | 18 | 20 | 41 | 112 | 237 | 197 | 299 | 278 | 565 | 609 | |
| Total Assets | 27 | 22 | 17 | 21 | 23 | 45 | 133 | 289 | 254 | 396 | 424 | 737 | 788 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | -11 | -11 | -60 | 33 | -33 | 59 | -154 | |||||
| 2 | -1 | -50 | -10 | 11 | -35 | -99 | -62 | |||||
| -1 | 16 | 62 | 85 | -45 | 117 | -7 | 214 | |||||
| Net Cash Flow | 3 | 3 | 2 | 15 | -0 | 49 | -47 | -1 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 11 | 3 | 1 | 3 | 3 | 50 | 32 | 40 | 33 | 29 | 33 |
| Inventory Days | 31 | 10 | 18 | 6 | 37 | 273 | 669 | 391 | 535 | 272 | 586 | |
| Days Payable | 2 | 5 | 5 | 21 | 0 | 11 | 147 | 24 | 24 | 7 | 60 | |
| Cash Conversion Cycle | 21 | 40 | 8 | 14 | -13 | 40 | 312 | 553 | 408 | 544 | 294 | 559 |
| Working Capital Days | 36 | 39 | 9 | 13 | -11 | 33 | 178 | 286 | 255 | 275 | 208 | 336 |
| ROCE % | 16% | 21% | 27% | 24% | 17% | 62% | 37% | 22% | 14% | 13% | 13% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Nov - Of Investor meet scheduled to be held on Monday, November 18, 2024.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Nov - Newspaper Publication for completion of dispatch of Postal Ballot Notice.
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 11 Nov
-
Intimation Of Incorporation Of Wholly Owned Subsidiary Company Under Regulation 30 Of SEBI (LODR) Regulation, 2015.
9 Nov - Incorporation of wholly owned subsidiary in Ghana.
-
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
7 Nov - Disclosure of share acquisition by Ashish Ramesh Saraf.
Annual reports
Concalls
-
Oct 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jul 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Apr 2021TranscriptNotesPPT
Market Position
Company is the world’s exclusive producer of Mango based Cocoa Butter Equivalent (CBE), Sal Based CBE, Shea-based CBE and Mango, Sal, Shea based Specialty fats and butter and is accredited with various certifications, recognized by GoI as a ‘Star Export House’ and is a member of FIEO, CII, SEDEX, APEDA, UNGC, SHEFEXIL, RSPO, IGBC, IOPEPC, SEA and others. [1]